… , and anesthesia symptoms as a surrogate for PN in breast cancer survivors. We included
patients with stage 0–III breast cancer who completed a clinical questionnaire at a survivorship …

… Breast cancer is the most common cancer among women worldwide, and survival rates are
increasing. Chemotherapy-associated peripheral neuropathy … peripheral sensory neuropathy …

… distress and falls among long-term breast cancer survivors. We conducted Cross-sectional …
breast cancer who received taxane-based chemotherapy. Participants reported neuropathic …

… breast cancer survivors in the United States experience long-term side effects of cancer therapy
including peripheral neuropathy (… of PN among women with breast cancer followed in the …

… Prevalence rates can be as high as 31.3% among all patients treated for breast cancer and
… will remain on managing the neuropathic aspect of pain following breast cancer surgery. …

… of breast cancer in Iran is much lower than its global average; therefore, some unknown
mechanisms may underline the association of age with PIPN in patients with breast cancer. …

… breast cancer patients treated with PTX as adjuvant chemotherapy at the National Cancer
… with PTX, those who presented with severe neuropathy before initiating PTX treatment, and …

… The program also considers the presence of comorbidities that could lead to non-cancer–related
mortality. If we were to use this program for our patient, her risk for breast cancer-…

… -induced peripheral neuropathy (CIPN) results from damage to or dysfunction of the peripheral
nerves. The development of CIPN is anticipated for the majority of breast cancer patients …

… participated in this study – 20 non-bed rest breast cancer patients after taxane-based
chemotherapy reporting neuropathy symptoms due to chemotherapy, and 16 healthy controls …